NASDAQ · Biotechnology

Iovance Biotherapeutics Inc (IOVA)

$8.29 -7.79%

Add alert

72 Overbought Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 200$3.39+144.54%

Company profile

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company is headquartered in San Carlos, California.

SectorHealthcare

IndustryBiotechnology

Market cap$2.90B

P/E ratioNone

EPS$-0.69

Beta0.701

Dividend yield0.00%

52-week high$6.92

52-week low$1.76

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 79 VRTX Vertex Pharmaceuticals Inc RSI 67 CRSP CRISPR Therapeutics AG RSI 67 MRNA Moderna Inc RSI 72 VKTX Viking Therapeutics Inc RSI 48 SRPT Sarepta Therapeutics Inc RSI 59 EDIT Editas Medicine Inc RSI 57 NVAX Novavax Inc RSI 63 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 46 RXRX Recursion Pharmaceuticals Inc - Class A RSI 59

Free forever

RSI alerts for IOVA

Get an email the moment Iovance Biotherapeutics Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 12 August 2026 at 6:56 AM EDT